Association of the Pattern of Retinal Capillary Non-Perfusion and Vascular Leakage with Retinal Neovascularization in Proliferative Diabetic Retinopathy

Overview

Journal J Curr Ophthalmol

Date 2021 Jun 4

PMID 34084958

Citations 6

Authors

Eric E Jung

Michelle Lin

Christine Ryu

Stavros N Moysidis

Bruce Burkemper

Rajan Murgai

Amirmohsen Arbabi

Hossein Ameri

Affiliations

Soon will be listed here.

Abstract

Purpose: To explore the correlation between retinal capillary non-perfusion and the distribution of retinal neovascularization and vascular leakage (VL) in patients with proliferative diabetic retinopathy (PDR).

Methods: Ultra-widefield angiograms of 96 eyes of 69 patients with PDR were reviewed for the proportion of non-perfused area to total gradable area, and for the presence of neovascularization and VL.

Results: Retinal neovascularization was distributed as such: neovascularization elsewhere (NVE), 57.3%; neovascularization of the disc (NVD), 11.5%; both neovascularization of the disc and elsewhere (NVED), 31.3%. The proportion of non-perfused retina, so-called ischemic index, was greater in eyes with NVED compared to eyes with NVE only, but not when compared to NVD only. Overall, 83% of eyes had VL. The presence and the extent of VL correlated with the proportion of the ischemic index. While VL and ischemic index were more severe in the mid-periphery and far-periphery, the majority of NVE was located in the posterior pole.

Conclusions: The presence of both NVD and NVE is associated with a greater ischemic index than NVE alone. Although both VL and ischemic index is significantly higher in peripheral zones, the majority of neovascularization occurs at the posterior pole.

Citing Articles

Microglia in retinal angiogenesis and diabetic retinopathy.

Hu A, Schmidt M, Heinig N Angiogenesis. 2024; 27(3):311-331.

PMID: 38564108 PMC: 11303477. DOI: 10.1007/s10456-024-09911-1.

Correlation analysis of Type-2 diabetes mellitus with proliferative retinopathy and central macular thickness.

Huang H, Jiang S, Niu H Pak J Med Sci. 2024; 40(4):642-647.

PMID: 38545017 PMC: 10963959. DOI: 10.12669/pjms.40.4.7726.

Assessment of area and structural irregularity of retinal layers in diabetic retinopathy using machine learning and image processing techniques.

Riazi-Esfahani H, Jafari B, Azimi H, Rahimi M, Saeidian J, Pouya P Sci Rep. 2024; 14(1):4013.

PMID: 38369610 PMC: 10874958. DOI: 10.1038/s41598-024-54535-6.

Is There a Nonperfusion Threshold on OCT Angiography Associated With New Vessels Detected on Ultra-Wide-Field Imaging in Diabetic Retinopathy?.

Le Boite H, Gaudric A, Erginay A, Tadayoni R, Couturier A Transl Vis Sci Technol. 2023; 12(9):15.

PMID: 37738057 PMC: 10519435. DOI: 10.1167/tvst.12.9.15.

Post-vitrectomy delayed retinal breaks in proliferative diabetic retinopathy.

Venkatesh R, Parmar Y, Mangla R, Sharief S, Yadav N, Chhablani J Int J Retina Vitreous. 2023; 9(1):7.

PMID: 36726158 PMC: 9890729. DOI: 10.1186/s40942-023-00444-1.

References

Valsania P, Warram J, Rand L, Krolewski A . Different determinants of neovascularization on the optic disc and on the retina in patients with severe nonproliferative diabetic retinopathy. Arch Ophthalmol. 1993; 111(2):202-6. DOI: 10.1001/archopht.1993.01090020056023. View

Wild S, Roglic G, Green A, Sicree R, King H . Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27(5):1047-53. DOI: 10.2337/diacare.27.5.1047. View

Koya D, King G . Protein kinase C activation and the development of diabetic complications. Diabetes. 1998; 47(6):859-66. DOI: 10.2337/diabetes.47.6.859. View

Lutty G, Cao J, McLeod D . Relationship of polymorphonuclear leukocytes to capillary dropout in the human diabetic choroid. Am J Pathol. 1997; 151(3):707-14. PMC: 1857840. View

Deckert T, Simonsen S, Poulsen J . Prognosis of proliferative retinopathy in juvenile diabetics. Diabetes. 1967; 16(10):728-33. DOI: 10.2337/diab.16.10.728. View

Kim J, Kim J, Jun H, Yu Y, Kim K . Inhibition of protein kinase C delta attenuates blood-retinal barrier breakdown in diabetic retinopathy. Am J Pathol. 2010; 176(3):1517-24. PMC: 2832170. DOI: 10.2353/ajpath.2010.090398. View

Baxter S, Ashir A, Nguyen B, Nudleman E . Quantification of Retinal Nonperfusion Associated With Posterior Segment Neovascularization in Diabetic Retinopathy Using Ultra-Widefield Fluorescein Angiography. Ophthalmic Surg Lasers Imaging Retina. 2019; 50(2):86-92. PMC: 6501581. DOI: 10.3928/23258160-20190129-04. View

Nicholson L, Ramu J, Chan E, Bainbridge J, Hykin P, Talks S . Retinal Nonperfusion Characteristics on Ultra-Widefield Angiography in Eyes With Severe Nonproliferative Diabetic Retinopathy and Proliferative Diabetic Retinopathy. JAMA Ophthalmol. 2019; 137(6):626-631. PMC: 6567981. DOI: 10.1001/jamaophthalmol.2019.0440. View

Silva P, Cavallerano J, Haddad N, Kwak H, Dyer K, Omar A . Peripheral Lesions Identified on Ultrawide Field Imaging Predict Increased Risk of Diabetic Retinopathy Progression over 4 Years. Ophthalmology. 2015; 122(5):949-56. DOI: 10.1016/j.ophtha.2015.01.008. View

10.

Bek T, Helgesen A . The regional distribution of diabetic retinopathy lesions may reflect risk factors for progression of the disease. Acta Ophthalmol Scand. 2001; 79(5):501-5. DOI: 10.1034/j.1600-0420.2001.790515.x. View

11.

Jansson R, Froystein T, Krohn J . Topographical distribution of retinal and optic disc neovascularization in early stages of proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 2012; 53(13):8246-52. DOI: 10.1167/iovs.12-10918. View

12.

Fan W, Nittala M, Velaga S, Hirano T, Wykoff C, Ip M . Distribution of Nonperfusion and Neovascularization on Ultrawide-Field Fluorescein Angiography in Proliferative Diabetic Retinopathy (RECOVERY Study): Report 1. Am J Ophthalmol. 2019; 206:154-160. DOI: 10.1016/j.ajo.2019.04.023. View

13.

Schroder S, Palinski W, Schmid-Schonbein G . Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. Am J Pathol. 1991; 139(1):81-100. PMC: 1886150. View

14.

Klein R, Klein B, Moss S, Davis M, DeMets D . The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1984; 102(4):520-6. DOI: 10.1001/archopht.1984.01040030398010. View

15.

Kern T, ENGERMAN R . Vascular lesions in diabetes are distributed non-uniformly within the retina. Exp Eye Res. 1995; 60(5):545-9. DOI: 10.1016/s0014-4835(05)80069-7. View

16.

Tan C, Chew M, van Hemert J, Singer M, Bell D, Sadda S . Measuring the precise area of peripheral retinal non-perfusion using ultra-widefield imaging and its correlation with the ischaemic index. Br J Ophthalmol. 2015; 100(2):235-9. DOI: 10.1136/bjophthalmol-2015-306652. View

17.

Soliman A, Silva P, Aiello L, Sun J . Ultra-wide field retinal imaging in detection, classification, and management of diabetic retinopathy. Semin Ophthalmol. 2012; 27(5-6):221-7. DOI: 10.3109/08820538.2012.708812. View

18.

Silva P, Dela Cruz A, Ledesma M, van Hemert J, Radwan A, Cavallerano J . Diabetic Retinopathy Severity and Peripheral Lesions Are Associated with Nonperfusion on Ultrawide Field Angiography. Ophthalmology. 2015; 122(12):2465-72. DOI: 10.1016/j.ophtha.2015.07.034. View

19.

Wong T, Klein R, Islam F, Cotch M, Folsom A, Klein B . Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol. 2006; 141(3):446-455. PMC: 2246042. DOI: 10.1016/j.ajo.2005.08.063. View

20.

Chibber R, Molinatti P, Kohner E . Intracellular protein glycation in cultured retinal capillary pericytes and endothelial cells exposed to high-glucose concentration. Cell Mol Biol (Noisy-le-grand). 1999; 45(1):47-57. View